bit.bio featured in TechRound's look forward at 2022.
bit.bio CEO Dr Mark Kotter joined several experts giving their thoughts on what is to come for the health sector in 2022. His focus was on what will happen in the cell therapy space coupled together with synthetic biology approaches.